21 September 2016
D-EYE Scores Well for Glaucoma Screening in Comparing the D-EYE Retinal imaging system with slit lamp technology
Comparison of Smartphone Ophthalmoscopy with Slit-Lamp Biomicroscopy for Grading Vertical Cup-to-Disc Ratio
Padova, Italy; Pasadena, CA, USA – September 20, 2016 – D-EYE, a leading developer of advanced devices for mass health screenings and data analytics is pleased to share the publication of a study comparing the D-EYE Retinal imaging system with slit lamp technology.
As indicated in the September 2016 issue of the Journal of Glaucoma, a study was performed to determine the agreement between D-EYE smartphone-based retinal ophthalmoscopy and slit-lamp indirect biomicroscopy when assessing vertical cup-to-disc ratios. One hundred and ten undilated patients participated in the study, some with ocular hypertension and others with primary open angle glaucoma.
The study concluded that D-EYE showed substantial agreement with slit-lamp examination for the estimation of the Vertical Cup-to-Disc Ratio (VCDR).
“The ubiquitous diffusion of the smartphones, together with their connectivity and portability features, enables an extensive benefit for this technology to be used in glaucoma screening, especially in low-resource settings.” (1)
The full study is available for Journal of Glaucoma subscribers at this link: http://journals.lww.com/glaucomajournal/Abstract/publishahead/Comparison_of_Smartphone_Ophthalmoscopy_With.98901.aspx
(1)Russo, Andrea MD; Mapham, William MD; Turano, Raffaele MD; Costagliola, Ciro MD; Morescalchi, Francesco MD; Scaroni, Nicolò MD; Semeraro, Francesco MD. (2016). Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Vertical Cup-to-Disc Ratio. Journal of Glaucoma, 25(9), 777-781.
Founded in 2014, with offices in Padova, Italy and Pasadena, CA, D-EYE Srl offers a "digital eye" into the state of the human body. The company designs and manufactures mobile sensing and examination devices, along with companion applications, that make possible mass health screenings and data collection to improve access to vital health examination services. D-EYE also develops and operates cloud-based Platform-as-a-Service (PaaS) systems that enable telehealth applications, and aggregate and analyze health-screening data to provide insight into individual conditions as well as trends across patient populations. The company's first product, developed in part with a grant from the Fondazione Cottino and with support from the University of Brescia (Italy), the revolutionary D-EYE Smartphone-based Retinal Imaging System focuses on eye care; subsequent mobile-health products and services will target screening and evaluation of other medical conditions and pathologies. For more information, please visit www.d-eyecare.com